Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer.
Chen J, Jin Y, Li S, Qiao C, Peng X, Li Y, Gu Y, Wang W, You Y, Yin J, Shan Y, Wang YX, Qin M, Li H, Cai Y, Dong Y, Peng S, Pan L.
Chen J, et al. Among authors: gu y.
Front Oncol. 2021 Oct 4;11:744256. doi: 10.3389/fonc.2021.744256. eCollection 2021.
Front Oncol. 2021.
PMID: 34671560
Free PMC article.